Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia.

• Tác giả: Leslie Citrome, Christoph U Correll, Andrew J Cutler, Martin Dunbar, Amber R Hoberg, Craig Hopkinson, Gregory W Mattingly, David McDonnell, James A McGrory, Bhaskar Rege, Peter J Weiden
• Ngôn ngữ: eng
• Ký hiệu phân loại: 809.008 History and description with respect to kinds of persons
• Thông tin xuất bản: New Zealand : Neuropsychiatric disease and treatment , 2025
• Bộ sưu tập: NCBI
• ID: 725029

Tóm tắt

This review article describes why and how aripiprazole was formulated as aripiprazole lauroxil (AL), an extended-release antipsychotic agent that is delivered via a long-acting injectable formulation, and the clinical trials investigating its use. AL was formulated as an inactive prodrug of aripiprazole using LinkeRx